{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/QNCX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T08:34:00.490Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":6734,"canonical_name":"Quince Therapeutics, Inc.","cik":"0001662774","uei":null,"lei":null,"duns":null,"ticker":"QNCX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":33},"count":33,"timeline":[{"ts":"2026-10-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — IRulya Therapeutics Inc. — 2026-10-14","url_slug":"/sec/cik-0001662774/schedule-13g/0001104659-26-115859","accession_number":"0001104659-26-115859","importance":55},{"ts":"2026-10-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-10-09","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-418538","accession_number":"0001193125-26-418538","importance":35},{"ts":"2026-10-08","kind":"sec.filing","form_type":"S-8","title":"S-8 — Quince Therapeutics, Inc. — 2026-10-08","url_slug":"/sec/cik-0001662774/s-8/0001193125-26-418091","accession_number":"0001193125-26-418091","importance":30},{"ts":"2026-10-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-10-06","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-415730","accession_number":"0001193125-26-415730","importance":35},{"ts":"2026-10-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-10-02","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-411260","accession_number":"0001193125-26-411260","importance":35},{"ts":"2026-10-02","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Quince Therapeutics, Inc. — 2026-10-02","url_slug":"/sec/cik-0001662774/defa14a/0001193125-26-411262","accession_number":"0001193125-26-411262","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-09-14","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-390652","accession_number":"0001193125-26-390652","importance":35},{"ts":"2026-09-04","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-382838","accession_number":"0001193125-26-382838","importance":35},{"ts":"2026-08-27","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-08-27","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-371389","accession_number":"0001193125-26-371389","importance":35},{"ts":"2026-08-25","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Quince Therapeutics, Inc. — 2026-08-25","url_slug":"/sec/cik-0001662774/def-14a/0001193125-26-364220","accession_number":"0001193125-26-364220","importance":40},{"ts":"2026-08-24","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Quince Therapeutics, Inc. — 2026-08-24","url_slug":"/sec/cik-0001662774/effect/9999999995-26-002741","accession_number":"9999999995-26-002741","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-08-17","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-353141","accession_number":"0001193125-26-353141","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Quince Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001662774/schedule-13g/0001193125-26-352966","accession_number":"0001193125-26-352966","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Quince Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001662774/10-q/0001193125-26-352201","accession_number":"0001193125-26-352201","importance":45},{"ts":"2026-08-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-350568","accession_number":"0001193125-26-350568","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-3/A","title":"S-3/A — Quince Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001662774/s-3-a/0001193125-26-333764","accession_number":"0001193125-26-333764","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Quince Therapeutics, Inc. — 2026-08-04","url_slug":"/sec/cik-0001662774/schedule-13g/0002050709-26-000021","accession_number":"0002050709-26-000021","importance":55},{"ts":"2026-07-31","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-07-31","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-328784","accession_number":"0001193125-26-328784","importance":35},{"ts":"2026-07-31","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Quince Therapeutics, Inc. — 2026-07-31","url_slug":"/sec/cik-0001662774/pre-14a/0001193125-26-328777","accession_number":"0001193125-26-328777","importance":30},{"ts":"2026-07-31","kind":"sec.filing","form_type":"S-3","title":"S-3 — Quince Therapeutics, Inc. — 2026-07-31","url_slug":"/sec/cik-0001662774/s-3/0001193125-26-328769","accession_number":"0001193125-26-328769","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — Quince Therapeutics, Inc. — 2026-07-30","url_slug":"/sec/cik-0001662774/8-k-a/0001193125-26-324786","accession_number":"0001193125-26-324786","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-06-26","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-284089","accession_number":"0001193125-26-284089","importance":35},{"ts":"2026-06-26","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — Quince Therapeutics, Inc. — 2026-06-26","url_slug":"/sec/cik-0001662774/8-k-a/0001193125-26-285572","accession_number":"0001193125-26-285572","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — Quince Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001662774/4/0000912282-26-000832","accession_number":"0000912282-26-000832","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-267862","accession_number":"0001193125-26-267862","importance":35},{"ts":"2026-06-11","kind":"sec.filing","form_type":"D","title":"D — Quince Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001662774/d/0000912282-26-000809","accession_number":"0000912282-26-000809","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"D","title":"D — Quince Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001662774/d/0000912282-26-000811","accession_number":"0000912282-26-000811","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-05-21","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-234858","accession_number":"0001193125-26-234858","importance":35},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Quince Therapeutics, Inc. — 2026-05-18","url_slug":"/sec/cik-0001662774/8-k/0001193125-26-228133","accession_number":"0001193125-26-228133","importance":35},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — Quince Therapeutics, Inc. — 2026-05-18","url_slug":"/sec/cik-0001662774/8-k-a/0001193125-26-228956","accession_number":"0001193125-26-228956","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Quince Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001662774/def-14a/0001193125-26-182255","accession_number":"0001193125-26-182255","importance":40},{"ts":"2026-04-27","kind":"sec.filing","form_type":"ARS","title":"ARS — Quince Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001662774/ars/0001193125-26-182282","accession_number":"0001193125-26-182282","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Quince Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001662774/defa14a/0001193125-26-182267","accession_number":"0001193125-26-182267","importance":30}]}